Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» rheumatoid arthritis
rheumatoid arthritis
Pfizer Sinks Despite Winning FDA Approval for Xeljanz XR
Yahoo/24-7 Wall St
Wed, 02/24/16 - 04:52 pm
Pfizer
FDA
Xeljanz XR
rheumatoid arthritis
Forget Biosimilars: It's This Threat That Could Dent AbbVie's Top Line
Motley Fool
Sun, 01/31/16 - 01:37 pm
AbbVie
biosimilars
Humira
baricitinib
rheumatoid arthritis
Incyte
Eli Lilly
Baxalta, Coherus say Enbrel biosimilar succeeds in study
Yahoo/Reuters
Mon, 01/11/16 - 08:36 am
Baxalta
Coherus Biosciences
biosimilars
Enbrel
rheumatoid arthritis
CHS-0214
AbbVie Announces the Launch of Robust Phase 3 Clinical Trial Program Evaluating ABT-494, an Investigational Selective JAK1 Inhibitor, for the Treatment of Rheumatoid Arthritis
Yahoo
Fri, 01/8/16 - 09:49 am
AbbVie
rheumatoid arthritis
JAK inhibitors
ABT-494
GSK gets lift from successful arthritis drug trials
Yahoo/Reuters
Wed, 12/16/15 - 10:57 am
GSK
rheumatoid arthritis
sirukumab
clinical trials
Sanofi and Regeneron Hit Another Bullseye
Motley Fool
Wed, 11/18/15 - 09:44 am
Sanofi
Regeneron
rheumatoid arthritis
Sarilumab
Amgen's Humira biosimilar clears Phase III and joins a crowd of contenders
Fierce Biotech
Wed, 11/11/15 - 10:04 am
Amgen
Humira
biosimilars
rheumatoid arthritis
Merck Discounts Remicade by 25% in U.K. to Fend Off Rivals
Bloomberg
Fri, 10/23/15 - 09:20 am
Merck
Remicade
UK
drug discounts
rheumatoid arthritis
Novartis biosimilar copycat takes aim at Amgen's drug Enbrel
Yahoo/Reuters
Fri, 10/2/15 - 10:37 am
Novartis
biosimilar
Amgen
Enbrel
rheumatoid arthritis
Sandoz
Lilly, Incyte rheumatoid arthritis drug succeeds in late-stage study
Yahoo/Reuters
Tue, 09/29/15 - 09:14 am
Eli Lilly
Incyte
rheumatoid arthritis
baricitinib
AbbVie dumps Galapagos' arthritis drug and presses on with its own
Fierce Biotech
Fri, 09/25/15 - 10:13 am
AbbVie
Galapagos
rheumatoid arthritis
ABT-494
JAK inhibitors
Merck and Samsung notch their first biosimilar victory with Enbrel knockoff
Fierce Biotech
Wed, 09/9/15 - 10:42 am
Merck
Samsung Bioepis
Enbrel
biosimilars
Amgen
rheumatoid arthritis
Galapagos starts timer on AbbVie buy-in decision with posting of final data
Fierce Biotech
Fri, 08/14/15 - 09:20 am
Galapagos
AbbVie
JAK inhibitors
rheumatoid arthritis
filgotinib
Merck and Samsung's Humira biosimilar comes through in Phase III
Fierce Biotech
Wed, 07/8/15 - 09:23 am
Merck
Humira
biosimilars
SB5
Samsung Bioepis
AbbVie
rheumatoid arthritis
Chi-Med Arthritis Drug Spurs Interest From Possible Partners
Bloomberg
Fri, 06/19/15 - 10:06 am
Chi-Med
HMPL-523
rheumatoid arthritis
Imbruvica
AbbVie
Biosim war heats up as Merck's Remicade & Enbrel biosimilars bag major wins in RA
BioPharma Dive
Wed, 06/10/15 - 11:10 am
Merck
Remicade
Enbrel
biosimilars
rheumatoid arthritis
Regeneron's arthritis drug nails it in phase III
BioPharma Dive
Fri, 05/22/15 - 10:44 am
Regeneron
Sarilumab
rheumatoid arthritis
Amgen Indulges in Another Rheumatoid Arthritis Drug Price Increase
TheStreet.com
Tue, 05/5/15 - 05:52 pm
Amgen
drug pricing
rheumatoid arthritis
Enbrel
Bullied in Norway, Merck Sees Sales of Blockbuster Dive
Bloomberg
Thu, 04/23/15 - 03:22 am
Merck
rheumatoid arthritis
Norway
Europe
Remicade
Protalex Initiates Enrollment of Phase I/II Continuation Trial of PRTX-100 in Active Rheumatoid Arthritis Patients
Yahoo
Fri, 03/13/15 - 09:42 am
Protalex
rheumatoid arthritis
PRTX-100
clinical trials
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »